Jingzhou ruidong pharmaceutical science and technology limited company's official website opened! Welcome to your visit

Jingzhou Ruidong Pharmaceutical Technology Co., Ltd. was established in 2021, covering an area of 100 acres, is located in the beautiful Jingzhou, focusing on the production and research and development of imidazole antifungal raw materials. Mainly to undertake large foreign pharmaceutical raw materials and intermediates production and sales business. The company has a modern production base and advanced production equipment. At present, it has three production workshops with an annual production capacity of 1500 tons. It is also equipped with a high-level laboratory and has established a close cooperative relationship with the doctoral laboratory of Hunan Central South University.

Read the difference between intermediates, APIs, excipients and preparations in one article.

Intermediate intermediate, a material produced in the API process steps that must undergo further molecular changes or refinement to become an API. An intermediate is a compound in the synthesis of an API and is an intermediate product in the synthesis of an API. Intermediates are the key products of the previous process of making API, which are different from the structure of API. Intermediates are only intermediate products in the process of synthesizing API, and do not need to obtain a document number or a drug production license. However, FDA (U.S. Drug Administration) requires that intermediates must be registered.

Imidazole antifungal drug mechanism of action

The mechanism of action of imidazole antifungal drugs is mainly to inhibit the growth of fungal cells, and then play an antifungal role. Imidazoles belong to a large class of antifungal drugs, including more drugs, according to their own circumstances prescribed medication.

Analysis on the Key Elements of Synthetic Process of API

An API is an active ingredient used in the manufacture of pharmaceutical preparations, usually made from a drug substance obtained through chemical synthesis, semi-synthesis, and microbial fermentation or natural product isolation, through the reaction of one or more chemical units and their manipulation. The study of drug synthesis process of API is an important part of drug research and production, which is the basis of drug research and development, and is an important part of drug quality formation.

Analysis of the R & D Process of API and Its Cost Composition

API refers to the active ingredients obtained by chemical synthesis, semi-synthesis, microbial fermentation or natural product separation, and made by one or more chemical unit reaction machines for the manufacture of pharmaceutical preparations. In the drug research and development process of API, the comprehensive analysis of the process is one of the important contents, through the comprehensive analysis can make the drug developers have a clear understanding of the advantages and disadvantages of the whole process, but also conducive to the technical evaluation of drugs. At present, China's API has shown a strong growth trend, but it is also facing the dual pressure of high cost and low quality. How to effectively control the cost of API is also one of the concerns of enterprises.

Analysis of Chinese Chemical Bulk Drugs and Intermediates Market

The production enterprises of chemical raw materials and intermediates in China can be divided into two categories, one is the regular API production enterprises with drug production license and production approval documents, and the other is the ordinary fine chemical plant, which mainly produces API intermediates and crude API. However, due to the high profits of some new drugs developed in recent years, many fine chemical manufacturers have rushed up and their output has increased rapidly, resulting in a rapid decline in the price of raw materials and fierce market fluctuations.